Combination therapy of vancomycin and piperacillin/tazobactam in adult febrile neutropenia patients with haematopoietic malignancies increases the risk of acute kidney injury regardless of vancomycin trough concentration

被引：3
|
作者：
Sazanami, Kohei [1 ,2 ]
Inose, Ryo [2 ]
Dote, Satoshi [1 ]
Horiuchi, Nozomu [1 ]
Kobayashi, Yuka [1 ]
Muraki, Yuichi [2 ]
机构：
[1] Kyoto Katsura Hosp, Dept Pharm, Kyoto, Japan
[2] Kyoto Pharmaceut Univ, Dept Clin Pharmacoepidemiol, Kyoto, Japan
来源：
JOURNAL OF CHEMOTHERAPY | 2021年 / 33卷 / 06期
关键词：
D O I：
10.1080/1120009X.2020.1848298
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] The association of high Vancomycin trough concentration with acute kidney injury during combination therapy of Piperacillin/Tazobactam and Vancomycin
    Saito, Syuichiro
    Sugimoto, Takeshi
    Takenaka, Kei
    Goto, Hideaki
    Kumahara, Akira
    Watanabe, Rikiya
    Sugiyama, Daisuke
    Yasutomo, Yoshiro
    Takatsuki, Kiyonobu
    PRACTICAL LABORATORY MEDICINE, 2022, 29
  • [2] Combinatorial Vancomycin and Piperacillin/Tazobactam Results in Elevated Vancomycin Trough Concentration and Acute Kidney Injury: A Case Report
    Sakai, Yoshiro
    Miwa, Ryoko
    Mitsuoka, Masahiro
    Watanabe, Hiroshi
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2020, 140 (05): : 751 - 754
  • [3] Risk factors for acute kidney injury in vancomycin and piperacillin/tazobactam combination therapy: A retrospective study
    Yamashita, Yuma
    Kawaguchi, Hiroshi
    Yano, Tsubasa
    Sakurai, Norihiro
    Shibata, Wataru
    Oshima, Kazuhiro
    Imai, Takumi
    Yamada, Koichi
    Nakamura, Yasutaka
    Nagayama, Katsuya
    Kakeya, Hiroshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (11) : 1614 - 1620
  • [4] Acute kidney injury and vancomycin/piperacillin/tazobactam in adult patients: a systematic review
    Ciarambino, Tiziana
    Giannico, Orazio Valerio
    Campanile, Amalia
    Tirelli, Paolo
    Para, Ombretta
    Signoriello, Giuseppe
    Giordano, Mauro
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (02) : 327 - 331
  • [5] Acute kidney injury and vancomycin/piperacillin/tazobactam in adult patients: a systematic review
    Tiziana Ciarambino
    Orazio Valerio Giannico
    Amalia Campanile
    Paolo Tirelli
    Ombretta Para
    Giuseppe Signoriello
    Mauro Giordano
    Internal and Emergency Medicine, 2020, 15 : 327 - 331
  • [6] Comparison of risk of acute kidney injury between patients receiving the combination of teicoplanin and piperacillin/tazobactam versus vancomycin and piperacillin/tazobactam
    Shao, Chi-Hao
    Tai, Chih-Hsun
    Lin, Fang-Ju
    Wu, Chien-Chih
    Wang, Jann-Tay
    Wang, Chi-Chuan
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (01) : 117 - 125
  • [7] Piperacillin-Tazobactam Added to Vancomycin Increases Risk for Acute Kidney Injury: Fact or Fiction?
    Avedissian, Sean N.
    Pais, Gwendolyn M.
    Liu, Jiajun
    Rhodes, Nathaniel J.
    Scheetz, Marc H.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (02) : 426 - 432
  • [8] Risk of Acute Kidney Injury in Patients on Concomitant Vancomycin and Piperacillin-Tazobactam Compared to Those on Vancomycin and Cefepime
    Navalkele, Bhagyashri
    Pogue, Jason M.
    Karino, Shigehiko
    Nishan, Bakht
    Salim, Madiha
    Solanki, Shantanu
    Pervaiz, Amina
    Tashtoush, Nader
    Shaikh, Hamadullah
    Koppula, Sunitha
    Koons, Jonathan
    Hussain, Tanveer
    Perry, William
    Evans, Richard
    Martin, Emily T.
    Mynatt, Ryan P.
    Murray, Kyle P.
    Rybak, Michael J.
    Kaye, Keith S.
    CLINICAL INFECTIOUS DISEASES, 2017, 64 (02) : 116 - 123
  • [9] Evaluating and Mitigating Risk of Acute Kidney Injury with the Combination of Vancomycin and Piperacillin-Tazobactam in Children
    Tillman, Emma M.
    Goldman, Jennifer L.
    PEDIATRIC DRUGS, 2021, 23 (04) : 373 - 380
  • [10] Combination of Piperacillin-Tazobactam and Vancomycin with a risk of Acute Kidney Injury: a French pharmacovigilance survey
    Cottin, J.
    Ollier, E.
    Page, A.
    Ferry, T.
    Osmont, M. N.
    Kheloufi, F.
    Gouraud, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 31 - 31
12345